The Manila Times

Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Advances to Expansion Phase in First-Line Biliary Tract Cancer Following Positive Safety and Preliminary ...

Nanjing Leads Biolabs Co., Ltd. ('Leads Biolabs” or the 'Company,” Stock Code: 9887.HK) announced that its proprietary PD-L1/4-1BB bispecific antibody, Opamtistomig (LBL-024), has successfully ...
Seeking Alpha

Rigel Announces First Patient Enrolled in the Dose Expansion Phase of its Phase 1b Study of R289 in Patients with Lower-Risk MDS

Dose expansion phase will determine the recommended Phase 2 dose of R289 for patients with transfusion dependent R/R lower-risk MDS SOUTH SAN FRANCISCO, Calif., Oct. 8, 2025 /PRNewswire/ -- Rigel ...
Morningstar

AdvanCell Initiates Phase 2 Expansion Trial of ADVC001, a Novel Targeted Alpha Therapy for Prostate Cancer

Clinical development of 212Pb-ADVC001 (ADVC001) is advancing rapidly with encouraging Phase 1b data presented at ESMO 2025 The Phase 2 expansion will evaluate 160 MBq and 200 MBq doses of ADVC001 ...
Hosted on MSN

ENB Greenlights Expansion of Mainline and Flanagan South Pipelines

Enbridge Inc. ENB, a leading pipeline operator in North America, has approved a major expansion project, named the Mainline Optimization Phase 1 project, worth $1.4 billion to expand the capacity of ...
The Scranton Times-Tribune

GCMC completes first phase of postpartum expansion

Geisinger Community Medical Center completed the first phase of its postpartum care expansion, opening 12 beds Dec. 1 on the hospital’s third floor, Geisinger announced this week. The service addition ...
Morningstar

SpliceBio Initiates Dose-Expansion Portion of Phase 1/2 ASTRA Clinical Trial for SB-007, a Dual-AAV Gene Therapy for Stargardt Disease

SpliceBio, a clinical-stage genetic medicines company pioneering protein splicing to address diseases caused by mutations in large genes, today announced that the first patient has been dosed in the ...